Astrana Health, Inc.
ASTH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,394,477 | $1,223,795 | $1,503,076 | $1,511,229 |
| - Cash | $462,227 | $339,703 | $258,517 | $288,455 |
| + Debt | $1,087,243 | $447,590 | $451,350 | $471,839 |
| Enterprise Value | $2,019,493 | $1,331,682 | $1,695,909 | $1,694,613 |
| Revenue | $956,048 | $654,808 | $620,390 | $665,209 |
| % Growth | 46% | 5.5% | -6.7% | – |
| Gross Profit | $81,597 | $77,969 | $71,329 | $63,016 |
| % Margin | 8.5% | 11.9% | 11.5% | 9.5% |
| EBITDA | $38,984 | $31,111 | $23,761 | $14,300 |
| % Margin | 4.1% | 4.8% | 3.8% | 2.1% |
| Net Income | $373 | $9,423 | $6,692 | -$6,951 |
| % Margin | 0% | 1.4% | 1.1% | -1% |
| EPS Diluted | -0.33 | 0.19 | 0.14 | -0.14 |
| % Growth | -273.7% | 35.7% | 200% | – |
| Operating Cash Flow | $9,956 | $90,900 | $16,627 | -$10,948 |
| Capital Expenditures | -$2,552 | -$1,420 | -$3,070 | -$2,531 |
| Free Cash Flow | $7,404 | $89,480 | $13,557 | -$13,479 |